Investment Intern with Novo Holdings Asia (Jan - Jun 2027)
Location: Singapore
Duration: January – June 2027 (Full-time, 6-month commitment)
About Novo Holdings
Novo Holdings is a leading international life science investor and the holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation. Headquartered in Copenhagen with offices in Asia, Europe, and North America, Novo Holdings manages over EUR 100 billion in assets across early-stage biotech, growth equity, and large public companies, alongside responsibility for supporting the Foundation’s philanthropic mission to improve health, sustainability, and life sciences globally.
For further information, visit www.novoholdings.dk
Asia Investments
Novo Holdings Equity Asia was established in 2020 to invest in the large and attractive life sciences market in the region. With offices in Singapore, Shanghai and Mumbai, we support healthcare companies across the continent, with a tailored approach to accommodate regional differences, participating across company life cycles and modalities including public equities, minority investments, co-investments and buyouts.
In Asia, we are committed to identifying and investing in life science and healthcare companies that are leading innovators in their field. Our investments cover a range
